3SBio Inc. (HKG:1530)
Hong Kong · Delayed Price · Currency is HKD 16.15
-1.76 (-9.83%)
Jul 17, 2026, 4:08 PM HKT
3SBio Market Cap
3SBio has a market cap or net worth of 40.33 billion as of July 17, 2026. Its market cap has decreased by -38.84% in one year.
Market Cap
40.33B
Enterprise Value
24.64B
Revenue
19.69B
Ranking
n/a
PE Ratio
4.23
Stock Price
16.15
ChartMarket Cap Chart
Since June 11, 2015, 3SBio's market cap has increased from 22.67B to 40.33B, an increase of 77.92%. That is a compound annual growth rate of 5.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 40.39B | -33.13% |
| Dec 31, 2025 | 60.39B | 321.75% |
| Dec 31, 2024 | 14.32B | -20.61% |
| Dec 29, 2023 | 18.04B | -10.89% |
| Dec 30, 2022 | 20.24B | 23.46% |
| Dec 31, 2021 | 16.40B | -8.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akeso | 95.34B |
| Sino Biopharmaceutical | 93.03B |
| RemeGen | 76.02B |
| Biocytogen Pharmaceuticals (Beijing) | 57.84B |
| Shanghai Junshi Biosciences | 38.41B |
| Shanghai Henlius Biotech | 34.51B |
| Genscript Biotech | 32.43B |
| InnoCare Pharma | 30.33B |